Tenet Healthcare
THC----
Q2 FY2026 EarningsQ2 2026 revenue rose 6.8% YoY to $5.63B, with Adjusted EBITDA growing 16.3% to $1.30B and margins expanding to 23.2% (up 1.9pct). Net income surged to $826M ($9.84 per diluted share), bolstered by a $413M contract termination gain. Management raised FY 2026 Adjusted EBITDA guidance by $295M at the midpoint to $4.93B and authorized an additional $2.0B share repurchase program.
Financial report interval: 2026.03.30 - 2026.06.30
Preview: Tenet Healthcare(THC) predict that the Revenue is 5.628 B (+6.77%), Beat estimate;the EBIT is 1.089 B (+19.28%), Beat estimate;the EPS is 9.84 (+213.4%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
5.63B6.77%
5.44B3.13%
+0.19B3.64%
EBITExceed expectations
1.09B19.28%
0.93B1.92%
+0.16B17.36%
EPSExceed expectations
9.84213.38%
5.72582.32%
+4.1150131.06%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf